Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Alaunos Therapeutics
Alaunos Therapeutics
Elicio Therapeutics
Elevation Oncology
Rain Oncology Inc
NextCure, Inc.
Hoffmann-La Roche
Incyte Corporation